Lipocine Inc. (LPCN) News
Follow Lipocine Inc. (LPCN) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 10 public stories across 5 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
M
Lipocine Reports Third-Quarter Revenue of $2.29 Million, EPS Loss of $0.08
Lipocine said revenue increased year over year and its net loss narrowed. Revenue included a $1.5 million collaboration fee, $600,000 in licensing revenue and TLANDO royalties; lower research and development expenses als
EQUITY | Nov 05, 2026, 02:43 PM UTC
M
Lipocine Q3 Revenue Surges on License and Royalty Income
EQUITY | Nov 05, 2026, 01:37 PM UTC
M
Lipocine Reports Third-Quarter Revenue of $2.3 Million
EQUITY | Nov 05, 2026, 01:04 PM UTC
M
Lipocine Reports Third-Quarter Loss Per Share
EQUITY | Nov 05, 2026, 01:04 PM UTC
M
Lipocine Announces Third-Quarter 2026 Financial Results
EQUITY | Nov 05, 2026, 01:02 PM UTC
H
Nasdaq Falls Over 100 Points; US Crude Inventories Decline
U.S. stocks traded lower midway through trading, with the Nasdaq Composite falling over 100 points on Wednesday. The Dow traded down 0.92% to 51,045.57 while the NASDAQ declined 0.41% to 27,485.79. The S&P 500 also fell,
LIVE | Oct 07, 2026, 04:02 PM UTC
L
LPCN - Lipocine to Present at the H.C. Wainwright 28th Annual Global Investment Conference
LPCN - Lipocine to Present at the H.C. Wainwright 28th Annual Global Investment Conference
EQUITY | Sep 10, 2026, 12:01 PM UTC
L
Lipoc to present at H.C. Wainwright conference Sept. 16
Lipocine Inc. will present and meet with investors at the H.C. Wainwright 28th Annual Global Investment Conference on Sept. 16, 2026. The webcast will be archived for 90 days.
EQUITY | Sep 10, 2026, 10:23 AM UTC
L
LPCN LPCN - Lipocine Announces Financial Results for the Second Quarter Ended June 30, 2026
LPCN LPCN - Lipocine Announces Financial Results for the Second Quarter Ended June 30, 2026
EARNINGS | Aug 04, 2026, 12:01 PM UTC
L
Lipocine Appoints Grissinger to Board
Lipocine appoints new board member
EQUITY | Aug 03, 2026, 12:01 PM UTC